Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Pulse Biosciences, Inc. Announces Exercise of Company Warrants

Dec 19, 2024•over 1 year ago

Contract Type

partnership

HaywardBiotechnologyHealth CareMedicalTherapeutics

Description

Pulse Biosciences, Inc. announced the exercise of warrants by its Co-Chairman and majority shareholder, Robert W. Duggan, corresponding to $58.4 million totaling to 5,306,156 shares of Company common stock. Mr

Company Information

Company

Pulse Biosciences, Inc.

Location

3957 POINT EDEN WAY

Hayward, California, United States

About

Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.

Related People

Suggested for you
Kevin
Likely contact at this company
••••••••@••••••••

See Kevin's verified email →

John
Senior decision-maker at this company
••••••••@••••••••

See John's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Pulse Biosciences, Inc.'s next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Pulse Biosciences, Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.